Okano Taisuke, Sato Kengo, Shirai Remina, Seki Tomomi, Shibata Koichiro, Yamashita Tomoyuki, Koide Ayaka, Tezuka Hitomi, Mori Yusaku, Hirano Tsutomu, Watanabe Takuya
Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Kita-15 Nishi-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
Int J Endocrinol. 2020 Mar 28;2020:4139093. doi: 10.1155/2020/4139093. eCollection 2020.
-Endorphin, an endogenous opioid peptide, and its -opioid receptor are expressed in brain, liver, and peripheral tissues. -Endorphin induces endothelial dysfunction and is related to insulin resistance. We clarified the effects of -endorphin on atherosclerosis. We assessed the effects of -endorphin on the inflammatory response and monocyte adhesion in human umbilical vein endothelial cells (HUVECs), foam cell formation, and the inflammatory phenotype in THP-1 monocyte-derived macrophages, and migration and proliferation of human aortic smooth muscle cells (HASMCs) in vitro. We also assessed the effects of -endorphin on aortic lesions in mice in vivo. The -opioid receptor (OPRM1) was expressed in THP-1 monocytes, macrophages, HASMCs, HUVECs, and human aortic endothelial cells. -Endorphin significantly increased THP-1 monocyte adhesion to HUVECs and induced upregulation of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin via nuclear factor-B (NF-B) and p38 phosphorylation in HUVECs. -Endorphin significantly increased HUVEC proliferation and enhanced oxidized low-density lipoprotein-induced foam cell formation in macrophages. -Endorphin also significantly shifted the macrophage phenotype to proinflammatory M1 rather than anti-inflammatory M2 via NF-B phosphorylation during monocyte-macrophage differentiation and increased migration and apoptosis in association with c-jun-N-terminal kinase, p38, and NF-B phosphorylation in HASMCs. Chronic -endorphin infusion into mice significantly aggravated the development of aortic atherosclerotic lesions, with an increase in vascular inflammation and the intraplaque macrophage/smooth muscle cell ratio, an index of plaque instability. Our study provides the first evidence that -endorphin contributes to the acceleration of the progression and instability of atheromatous plaques. Thus, -opioid receptor antagonists may be useful for the prevention and treatment of atherosclerosis.
内啡肽是一种内源性阿片肽,其μ-阿片受体在脑、肝脏和外周组织中表达。内啡肽可诱导内皮功能障碍并与胰岛素抵抗相关。我们阐明了内啡肽对动脉粥样硬化的影响。我们评估了内啡肽对人脐静脉内皮细胞(HUVECs)炎症反应和单核细胞黏附、泡沫细胞形成、THP-1单核细胞衍生巨噬细胞的炎症表型以及体外人主动脉平滑肌细胞(HASMCs)迁移和增殖的影响。我们还评估了内啡肽对载脂蛋白E基因敲除小鼠体内主动脉病变的影响。μ-阿片受体(OPRM1)在THP-1单核细胞、巨噬细胞、HASMCs、HUVECs和人主动脉内皮细胞中表达。内啡肽显著增加THP-1单核细胞与HUVECs的黏附,并通过核因子-κB(NF-κB)和p38磷酸化诱导HUVECs中细胞间黏附分子-1、血管细胞黏附分子-1和E-选择素的上调。内啡肽显著增加HUVECs增殖并增强巨噬细胞中氧化型低密度脂蛋白诱导的泡沫细胞形成。在单核细胞-巨噬细胞分化过程中,内啡肽还通过NF-κB磷酸化显著将巨噬细胞表型转变为促炎M1而非抗炎M2,并增加HASMCs中与c-jun-末端激酶、p38和NF-κB磷酸化相关的迁移和凋亡。向载脂蛋白E基因敲除小鼠慢性输注内啡肽显著加重主动脉粥样硬化病变的发展,伴有血管炎症增加和斑块内巨噬细胞/平滑肌细胞比率升高,这是斑块不稳定的一个指标。我们的研究提供了首个证据,表明内啡肽有助于加速动脉粥样硬化斑块的进展和不稳定性。因此,μ-阿片受体拮抗剂可能对动脉粥样硬化的预防和治疗有用。